CPE Media News (5/4/2020) – Ayogo Health Inc. has closed a $7.5 million Series B round of financing. New investors in the round include Baxter International Inc. and MEDTEQ, the pan-Canadian Consortium for Industrial Research and Innovation in Medical Technology. All investors in the Series A financing round participated in this new financing, including Merck Global Health Innovation Fund (GHI), 7Wire Ventures, and Excel Venture Management.
“We are delighted to be working with investment partners that understand the potential our products have to improve health outcomes while reducing costs, and to positively impact the lives of patients, families, and clinicians. In this challenging time it is both a great honor and responsibility to have received the capital to help grow and accelerate our mission and business, and we intend to maintain our focus on leveraging advanced technology and cutting-edge behavioral science to improve the human condition.” Michael Fergusson, CEO at Ayogo.
Founded in 2011 and formerly Prefer Health Networks, Ayogo Health is an eHealth company that transforms the way consumers with chronic conditions engage with their own care. Ayogo’s behavioral support platform creates value for innovative medical device and life sciences companies by helping patients successfully transition on to therapy.
In 2015, Ayogo Health raised $2.5 million Series A funding from Merck, Excel, and 7Wire Ventures, with David Stevenson of GHI, Caleb Winder of Excel, and Lee Shapiro of 7Wire joining Ayogo’s board of directors.
photo credit: AyogoNews Release
Financing to accelerate growth of Ayogo’s healthcare engagement platform.
VANCOUVER, British Columbia, (April 29, 2020) – Ayogo Health Inc. has successfully raised a $7.5M Series B financing round. The round was raised from several high-profile investors to propel its mission and vision: to activate, engage and empower patients faced with challenging transitions in care. Ayogo’s behavioral support platform creates value for innovative medical device and life sciences companies by helping patients successfully transition on to therapy. The company’s “dynamic tailoring” technology ensures patients receive personal, relevant, and timely support based on each patient’s unique psychosocial context.
New investors in the round include Baxter International Inc. and MEDTEQ, the pan-Canadian Consortium for Industrial Research and Innovation in Medical Technology. All investors in the Series A financing round participated in this new financing, including Merck Global Health Innovation Fund, 7Wire Ventures, and Excel Venture Management.
Michael Fergusson, CEO at Ayogo, commented: “We are delighted to be working with investment partners that understand the potential our products have to improve health outcomes while reducing costs, and to positively impact the lives of patients, families, and clinicians. In this challenging time it is both a great honor and responsibility to have received the capital to help grow and accelerate our mission and business, and we intend to maintain our focus on leveraging advanced technology and cutting-edge behavioral science to improve the human condition.”
About Ayogo
At Ayogo, we activate, engage and empower patients faced with challenging healthcare transitions. Ayogo’s highly-scalable behavioral support platform creates value for innovative life sciences companies by helping their patients successfully transition on to therapy. Our “dynamic tailoring” technology allows us to ensure the support we provide is personal, relevant, and timely, and based on each patient’s unique psychosocial context.
Our growing team cares deeply about doing meaningful, innovative work: we’ve developed a product that empowers patients and providers around the globe, while creating a culture that nourishes this spirit. Ayogo has twice been recognized as one of the top 100 most innovative digital health companies, and is broadly recognized for its progressive corporate culture.
To learn more, visit www.ayogo.com and follow on Twitter, LinkedIn and Facebook